Vitamin B12 Analogues, Homocysteine, Methylmalonic Acid, and Transcobalamins in the Study of Vitamin B12 Deficiency in Primary Degenerative DementiaRegland B.a · Abrahamsson L.b · Gottfries C.G.a · Magnus E.c
a Department of Psychiatry, St. Jörgen Hospital, University of Göteborg, and b Department of Clinical Chemistry, Uddevalla Hospital, Uddevalla, Sweden; c Hematology Section, Ullevål Hospital, Oslo, Norway
Dr. Björn Regland, Department of Geriatrics and Rehabilitation, Rosenhäll, Uddevalla Hospital, S-451 80 Uddevalla (Sweden)
Do you have an account?
B12 analogues, homocysteine, methylmalonic acid (MMA), and unsaturated transcobalamins, all potential markers of vitamin B12 status, were analyzed in blood and cerebrospinal fluid (CSF) from 22 patients with primary degenerative dementia of Alzheimer type. The level of active vitamin B12 in serum correlated significantly with serum homocysteine, serum MMA, and CSF homocysteine. CSF B12 correlated significantly with serum homocysteine and serum MMA. The ratio of analogues and active vitamin B12 concentrations in serum (analogue/active B12 ratio) correlated significantly with serum homocysteine, serum MMA and CSF B12. This study had no control group. However, based on available reference values, high concentrations of homocysteine and MMA in serum and unsaturated transcobalamin II in plasma were interpreted as evidence of vitamin B12 depletion or deficiency. Such high concentrations were found in a significant number of patients. In 9 patients, vitamin B12 injections were administered. After treatment, serum homocysteine levels fell significantly. We conclude that vitamin B12 analogues, homocysteine, MMA, and transcobalamins may be useful as markers in studies aimed at clarifying the role of vitamin B12 deficiency in dementia disorders.
© 1990 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.